Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery

NCT03074318 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

35

Enrollment

OTHER

Sponsor class

Stopped Terminated due to PI leaving institution

Conditions

Metastatic Leiomyosarcoma
Metastatic Liposarcoma
Unresectable Leiomyosarcoma
Unresectable Liposarcoma

Interventions

DRUG: Avelumab
DRUG: Trabectedin

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]
[object Object]